The College is pleased to announce that its NICE accredited process for developing guidelines ‘Guidance for authors on writing guidelines’ has been approved and renewed for a further 5 years until July 2022. The NICE accreditation mark will now appear on all College clinical guidelines.
The College produces a range of products for pathologists. These include cancer datasets and tissue pathways, the development process for which, was accredited by NICE accreditation team in 2012 for 5 years. When the accreditation term ended the College submitted an extended version of its guideline writing process to cover all Clinical Effectiveness guideline products (not just datasets and tissue pathways).
A key priority for the College is the maintenance of its NICE accreditation status as the accreditation mark help users identify trusted guidelines that have been developed using a critically evaluated high-quality process. It also helps improve the quality of information produced for healthcare decision makers.